Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1255332 | 0.79 | SLC7A5 (0.35) | HDAC1HDAC11HDAC8HDAC6GLA | |
| SCHEMBL27537070 | 0.77 | HDAC1 (0.40) | HDAC1HDAC11HDAC8HDAC6GLA | |
| SCHEMBL27842941 | 0.77 | HDAC1 (0.40) | HDAC1HDAC11HDAC8HDAC6GLA | |
| SCHEMBL28001240 | 0.77 | HDAC1 (0.40) | HDAC1HDAC11HDAC8HDAC6GLA | |
| SCHEMBL27758869 | 0.77 | HDAC1 (0.40) | HDAC1HDAC11HDAC8HDAC6GLA | |
| SCHEMBL15412977 | 0.76 | HDAC1 (0.33) | HDAC1HDAC11HDAC8HDAC6GLA | |
| SCHEMBL3465369 | 0.76 | HDAC1 (0.38) | HDAC1HDAC11HDAC8HDAC6GLA | |
| SCHEMBL4948031 | 0.76 | HDAC1 (0.38) | HDAC1HDAC11HDAC8HDAC6GLA | |
| SCHEMBL14777348 | 0.74 | HDAC1 (0.33) | HDAC1HDAC11HDAC8HDAC6GLA | |
| SCHEMBL25440569 | 0.74 | HDAC1 (0.39) | HDAC1HDAC11HDAC8HDAC6GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120292577-A1 | REGIOREGULAR POLYTHIOPHENE AND PROCESS FOR PRODUCTION THEREOF | KURARAY CO., LTD. (JP) | 2012-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120292577-A1 | REGIOREGULAR POLYTHIOPHENE AND PROCESS FOR PRODUCTION THEREOF | NTRK1, ETV1, EPB41 | HDAC1 2361/4885HDAC11 3592/4885HDAC8 4837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.